July 21, 2022 10:49 AM EDTUpdated July 22, 02:33 PM
FDA+
Manufacturing

Up­dat­ed: Span­ish he­parin man­u­fac­tur­er draws the ire of the FDA in its lat­est warn­ing over qual­i­ty con­cerns

Tyler Patchen

News Reporter

Span­ish he­parin and API man­u­fac­tur­er Bioiber­i­ca is still not in the clear as far as the FDA is con­cerned, with a new warn­ing let­ter re­lat­ed …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times